Estimates of the value of life lost from COVID-19 in Ohio
Publication: Journal of Comparative Effectiveness Research
Abstract
The economic burden of mortality due to the novel coronavirus (COVID-19) extends beyond the lives lost. Data from the Ohio Department of Public Health and Social Security Administration was used to estimate the years of potential life lost, 72,274 and economic value of those lost lives, US$17.39 billion. These estimates may be used to assess the risk-trade off of COVID-19 mitigation strategies in Ohio.
Formats available
You can view the full content in the following formats:
References
Papers of special note have been highlighted as: • of interest
1.
Kniesner TJ, Viscusi WK. The value of a statistical life. Forthcoming Oxford Research Encyclopedia of Economics and Finance Vanderbilt Law Research Paper No. 19-15. SSRN (2019). http://dx.doi.org/10.2139/ssrn.3379967
• Provides a foundational overview of the value of statistical lifefor those interested in further reading on this topic.
2.
O'Brien J. Age, autos and the value of a statistical life. J. Risk Uncertainty 57(1), 51–79 (2018).
3.
Elledege SJ. 2.5 million person-years of life have been lost due to COVID-19 in the United States. medRxiv.org(2020). https://doi.org/10.1101/2020.10.18.20214783
4.
Navarro A. Governors take the lead in the fight against coronavirus. CBS news website. (2020). https://www.cbsnews.com/news/governors-take-the-lead-in-the-fight-against-coronavirus/
5.
Ohio Department of Public Health. COVID-19 Dashboard website (2010). https://coronavirus.ohio.gov/wps/portal/gov/covid-19/dashboards/overview
6.
Social Security Administration. Actuarial Life Table website (2020). www.ssa.gov/oact/STATS/table4c6.html#fn2
7.
Bell FC, Miller ML. Life Tables for the United States Social Security Area 1900–2100: Actuarial Study No. 120 website (2020). www.ssa.gov/oact/NOTES/as120/LifeTables_Body.html
8.
Adler MD. What should we spend to save lives in a pandemic? A critique of the value of statistical life (25 June 2020). Duke Law School Public Law & Legal Theory Series No. 2020–40. SSRN (2020). http://dx.doi.org/10.2139/ssrn.3636550
• Value of statistical life method used in this study is not without controversy. This study provides a critique of the method.
9.
Robinson LA, Sullivan R, Shogren JF. Do the benefits of COVID-19 policies exceed the costs? Exploring uncertainties in the age-VSL relationship. Risk Anal. (2020) (Epub ahead of print).
10.
Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): vaccines (2020). www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html
Information & Authors
Information
Published In
Pages: 281 - 284
PubMed: 33594901
Copyright
© 2021 Future Medicine Ltd.
History
Received: 6 November 2020
Accepted: 14 December 2020
Published online: 17 February 2021
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Estimates of the value of life lost from COVID-19 in Ohio. (2021) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2020-0245
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Mohammad Almari, Stephen O’Neill, Zia Sadique, The economic burden of COVID-19 premature mortality in Kuwait, BMC Public Health, 10.1186/s12889-025-25940-x, 26, 1, (2025).
- Shalinie Mahadeo, Briana Lui, Elizabeth Khusid, Marissa Weber, Rohan Jotwani, Marguerite Hoyler, Robert S. White, Economic losses resulting from opioid overdose deaths in the United States between 2018 and 2020: By opioid type, Journal of Opioid Management, 10.5055/jom.0871, 20, 5, (375-381), (2024).
- Constantine Vardavas, Konstantinos Zisis, Katerina Nikitara, Ioanna Lagou, Valia Marou, Katerina Aslanoglou, Konstantinos Athanasakis, Revati Phalkey, Jo Leonardi-Bee, Esteve Fernandez, Orla Condell, Favelle Lamb, Frank Sandmann, Anastasia Pharris, Charlotte Deogan, Jonathan E Suk, Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU/UK/OECD: a systematic review, BMJ Open, 10.1136/bmjopen-2023-077602, 13, 10, (e077602), (2023).
- Kathryn Maguire-Jack, Kenneth J. Steinman, Julia Lesnick, Atticus Solomon, Kristopher West, Kathleen Roush, Kayla Zimpfer, Nancy Cunningham, Implementing Triple P during the COVID-19 pandemic with families at risk for substance use, Child Abuse & Neglect, 10.1016/j.chiabu.2022.105636, 129, (105636), (2022).
- Cuong Vu Manh, Weeks of life lost to COVID‐19, the case of the United States, Immunity, Inflammation and Disease, 10.1002/iid3.661, 10, 7, (2022).
- Michelle Zheng, Briana Lui, Axell-Giovanni A Komlan, Christina R Bonaparte, Robert S White, Marguerite M Hoyler, Economic burden of lives lost due to COVID-19 in California State, Journal of Comparative Effectiveness Research, 10.2217/cer-2021-0245, 11, 7, (489-498), (2022).
- Jay J. Xu, Jarvis T. Chen, Thomas R. Belin, Ronald S. Brookmeyer, Marc A. Suchard, Christina M. Ramirez, Male-Female Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: A State-by-State Analysis, Applied Sciences, 10.3390/app11167403, 11, 16, (7403), (2021).
- Briana Lui, Michelle Zheng, Robert S White, Marguerite Hoyler, Economic burden of lives lost due to COVID-19 in New York State, Journal of Comparative Effectiveness Research, 10.2217/cer-2021-0086, 10, 11, (893-897), (2021).
- Wei-Chun Wang, Jean Ching-Yuan Fann, Ray-E Chang, Ya-Chung Jeng, Chen-Yang Hsu, Hsiu-Hsi Chen, Jin-Tan Liu, Amy Ming-Fang Yen, Economic evaluation for mass vaccination against COVID-19, Journal of the Formosan Medical Association, 10.1016/j.jfma.2021.05.020, 120, (S95-S105), (2021).
- Chiao-Yun Fan, Jean Ching-Yuan Fann, Ming-Chin Yang, Ting-Yu Lin, Hsiu-Hsi Chen, Jin-Tan Liu, Kuen-Cheh Yang, Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics, Journal of the Formosan Medical Association, 10.1016/j.jfma.2021.05.019, 120, (S106-S117), (2021).